MELVILLE, N.Y.– Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care products and services to office-based dental and medical practitioners, today announced that it has amended its revolving credit facility, including an increase in the maximum borrowing amount from $750 million to $1 billion, and an extension of the facility through August 2026. JP Morgan Securities LLC and U.S. Bank NA served as Joint Lead Arrangers for the new facility.
“We are pleased to announce the increase of our credit facility, which provides us with greater flexibility to allocate capital in support of our strategic plan,” said Steven Paladino, Executive Vice President and Chief Financial Officer of Henry Schein. “The facility also supports our long-term internal and acquisition growth strategies.”
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 21,000 Team Schein Members worldwide, the Company’s network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental and medical laboratories, government and institutional health care clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.
A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries and territories. The Company’s sales reached $10.1 billion in 2020, and have grown at a compound annual rate of approximately 12 percent since Henry Schein became a public company in 1995.
